

QUICK LINKS
A intermediate of the metabolite of Atorvastin, a selective, competitive HMG-CoA reductase inhibitor. Atorvastin is the only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
N-4-Benzyloxyphenyl α-Benzilidene Isobutyrylacetamide, 10 mg | sc-207944  | 10 mg  | $360.00 |